123 A New Alternative for Acne Treatment The results revealed that microsponges have promising potential in the textile field, and this could be successfully transferred to textile materials. In this study, HPMC, which is widely used to delay drug release in pharmacology, was also used in the textile field as a binder. Despite their particle sizes of around 110 µm, microsponges were fixed on the fabric surface with an acrylic binder, particularly with HPMC used to keep the particles at a large size. ACKNOWLEDGMENTS This work was supported by the TUBITAK Scientific and Technological Research Council, Project 117M350. REFERENCES (1) H.C. Williams, R.P. Dellavalle, and S. Garner, Acne vulgaris, Lancet., 379(9813), 361–372 (2012). (2) A. Vyas, A.K. Sonker, and B. Gidwani, Carrier-based drug delivery system for treatment of acne, ScientificWorldJournal, 276260 (2014). (3) R. Kubba, A.K. Bajaj, D.M. Thappa, R. Sharma, M. Vedamurthy, S. Dhar, S. Criton, R. Fernandez, A. J. Kanwar, U. Khopkar, M. Kohli, V.P. Kuriyipe, K. Lahiri, N. Madnani, D. Parikh, S. Pujara, K.K. Rajababu, S. Sacchidanand, V.K. Sharma, and J. Thomas, Combination therapy, Indian J. Dermatol. Venereol., 75(1), 5–9 (2009). (4) E. Makrantonaki, R. Ganceviciene, and C. Zouboulis, An update on the role of the sebaceous gland in the pathogenesis of acne, Dermatoendocrinol., 3(1), 41–49 (2011). (5) E.A. Tanghett, The role of inflammation in the pathology of acne, J. Clin. Aesthet. Dermatol., 6(9), 27–35 (2013). (6) A. Yarpuz, E. Saadet, H. Şanlı, and H. Özgüven, Akne vulgaris hastalarında sosyal kaygı düzeyi ve bunun klinik değişkenler ile ilişkisi, Türk psikiyatri dergisi, 19(1), 29–37 (2008). (7) J.J. Leyden, A review of the use of combination therapies for the treatment of acne vulgaris, J. Am. Acad. Dermatol., 49(3), S200–S210 (2003). (8) C. Brammann and C.C. Müller-Goymann, An update on formulation strategies of benzoyl peroxide in efficient acne therapy with special focus on minimizing undesired effects, Int. J. Pharm., 30(578), 119074 (2020). (9) V. Nierstrasz, “Textile-based drug release systems,” in Smart Textiles for Medicine and Healthcare, L. Van Langenhove. Ed. (Woodhead, Cambridge, 2007), p. 50. (10) K.E. Uhrich, S.M. Cannizzaro, R.S. Langer, and K.M. Shakesheff, Polymeric systems for controlled drug release, Chem. Rev., 99(11), 3181–3198 (1999). (11) A.A. Date, B. Naik, and M.S. Nagarsenker, Novel drug delivery systems: potential in improving topical delivery of antiacne agents, Skin Pharmacol. Physiol., 19(1), 2–16 (2006). (12) T. Gabriel, Topical antiacne drugs delivery systems, The Open Dermatology Journal, 10, 85–95 (2016). (13) E. Yazıcı, S.H. Kaş, and A.A. Hıncal, Microsponges, Fabad J. Pharm. Sci., 19(3), 121–128 (1994). (14) T. Çomoğlu and N. Gönül, Microsponge delivery systems, Ankara Univ. Eczacilik Fak. Derg., 29(2), 75–86 (2000). (15) S.H. Kaş, “İlaç taşıyıcı partiküler sistemler,” in Kontrollü SalımSsistemleri, A. Zırh-Gürsoy. Ed. (Kontrollü Salım Sistemleri Derneği, İstanbul, 2017), pp. 94–99. (16) S. Subhash and S. Nacht, “Polymeric porous delivery systems,” in Delivery System Handbook for Personal Care and Cosmetic Products, M. Rosen. Ed. (William Andrew Inc., New York, 2005), pp. 338–344. (17) S. Feldman, R.E. Careccıa, K.L. Barham, and J. Hancox, Diagnosis and treatment of acne, Amerıcan Famıly Physıcıan, 69(9), 2123–2130 (2004).

124 JOURNAL OF COSMETIC SCIENCE (18) K. Degitz, M. Placzek, C. Borelli, and G. Plewig, Pathophysiology of acne, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 5(4), 316–323 (2007). (19) M. Sagransky, B.A. Yentzer, and S.R. Feldman, Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris, Expert Opin. Pharmacother., 10(15), 2555–2562 (2009). (20) M.H. Lee, J.R. Chen, M. Das, T.F. Hsieh, and C.M. Shu, Thermokinetic parameter evaluation by DSC and TAM III along with accountability of mass loss by TG from the thermal decomposition analyses of benzoyl peroxide, J. Therm. Anal. Calorim., 122(3), 1143–1150 (2015). (21) Benzoyl Peroxide (Topical Route), Mayo Clinic, accessed March 18, 2019, https://www.ema.europa.eu/en/ documents/scientific-guideline/ich-q-2-r1-validation-analytical-procedures-text-methodology-step-5_ en.pdf. (22) Y. Kawashima, T. Niwa, T. Handa, H. Takeuchi, T. Iwamoto, and Y. Itoh, Preparation of prolonged- release spherical micro-matrix of ibuprofen with acrylic polymer by the emulsion-solvent diffusion method for improving bioavailability, Chem. Pharm. Bull., 37(2), 425–429 (1989). (23) M. Jelvehgari, M.R. Siahi-Shadbad, S. Azarmi, G.P. Martin, and A. Nokhodchi, The microsponge delivery system of benzoyl peroxide: preparation, characterization and release studies, Int. J. Pharm., 308(1–2), 124–132 (2006). (24) ICHHT Guideline, Validation of Analytical Procedures Q2(R1) (2005), accessed June 1, 2022, https:// www.ema.europa.eu/en/documents/scientific-guideline/ich-q-2-r1-validation-analytical-procedures-text- methodology-step-5_en.pdf. (25) S.Y. Karavana, Z. Ay Şenyiğit, Ç. Çalışkan, G. Sevin, D. İlem Özdemir, Y. Erzurumlu, S. Şen, and E. Baloğlu, Gemcitabine hydrochloride microspheres used for intravesical treatment of superficial bladder cancer: a comprehensive in vitro/ex vivo/in vivo evaluation, Drug Des. Devel. Ther., 12, 1959–1975 (2018). (26) B.Y. Shekunov, P. Chattopadhyay, H.H. Tong, and A.H. Chow, Particle size analysis in pharmaceutics: principles, methods and applications, Pharm. Res., 24(2): 203–227 (2007). (27) A.F. El-Kattan, C.S. Asbill, and B.B. Michniak, The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems, Int. J. Pharm., 198(2), 179–189 (2000). (28) N. Pekel, F. Yoshii, T. Kume, and O. Güven, Radiation crosslinking of biodegradable hydroxypropylmethylcellulose, Carbohydr. Polym., 55(2), 139–147 (2004).